Suzuki Hiromichi, Kanno Yoshihiko, Nakamoto Hidetomo, Okada Hirokazu, Sugahara Souichi
Department of Nephrology, Saitama Medical School, Saitama, Japan.
Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):129-38.
The aim of this study was to investigate a significance of increased proteinuria in the morning and the effects of antihypertensive treatment on proteinuria and arterial blood pressure in the progression of chronic renal insufficiency in type 2 diabetic patients with hypertension and nephropathy. In three 24-hr urine samples and blood pressure monitoring, separated into a night-and daytime and spot urine in the morning, variation in protein-creatinine ratio (g/g) and blood pressure were assessed in 24 (58 +/- 3 years old; M/F: 17/7) diabetic patients with hypertension and nephropathy. Furthermore, the effects of antihypertensive therapy of combinations of angiotensin converting enzyme (ACE) inhibitor, calcium antagonists, diuretics, and alpha1 blocker were evaluated in 3 years. Home blood pressure measurement was carried out every month and 24-hr urine was collected every 2 months. The baseline urine excretion of protein-creatinine ratio and blood pressure were (1.22 +/- 0.13 g/g creatinine: 154/96 +/- 6/5 mmHg) in daytime and (1.39 +/- 0.13: 168/88 +/- 15/7) in the morning. At the end of the study, significant associations among a decline of 24-hr creatinine clearance and both of the urine excretion of protein-creatinine ratio (r = 0.47, p < .01) and the levels of systolic blood pressure (r = 0.46, p < .01) and between the levels of systolic blood pressure and the urine excretion of protein-creatinine ratio in the morning (r = 0.57, p < .001) were demonstrated. However, there were no significant associations among other variables. Analysis of patients who had systolic blood pressure in the morning less than 140 mmHg revealed that 65% of these patients received doxazosin-averaged doses of 4.8 +/- 1.5 mg daily. The levels of both blood pressure and proteinuria-creatinine ratio in the morning mainly associate with progression of renal function in diabetic patients with hypertension and nephropathy.
本研究旨在探讨2型糖尿病合并高血压及肾病患者慢性肾功能不全进展过程中晨起蛋白尿增加的意义,以及降压治疗对蛋白尿和动脉血压的影响。在24例(年龄58±3岁;男/女:17/7)糖尿病合并高血压及肾病患者中,通过采集三份24小时尿样并进行血压监测,将其分为夜间、白天和晨起随机尿样,评估尿蛋白肌酐比值(g/g)和血压的变化。此外,在3年时间里评估了血管紧张素转换酶(ACE)抑制剂、钙拮抗剂、利尿剂和α1受体阻滞剂联合降压治疗的效果。每月进行家庭血压测量,每2个月收集24小时尿样。白天尿蛋白肌酐比值和血压的基线排泄量分别为(1.22±0.13 g/g肌酐:154/96±6/5 mmHg),晨起为(1.39±0.13:168/88±15/7)。研究结束时,24小时肌酐清除率的下降与尿蛋白肌酐比值的排泄量(r = 0.47,p <.01)、收缩压水平(r = 0.46,p <.01)以及晨起收缩压水平与尿蛋白肌酐比值之间(r = 0.57, p <.001)均显示出显著相关性。然而,其他变量之间未发现显著相关性。对晨起收缩压低于140 mmHg的患者分析显示,这些患者中有65%接受了多沙唑嗪治疗,平均每日剂量为4.8±1.5 mg。晨起血压和蛋白尿肌酐比值水平主要与糖尿病合并高血压及肾病患者的肾功能进展相关。